CH595106A5 - - Google Patents

Info

Publication number
CH595106A5
CH595106A5 CH279375A CH279375A CH595106A5 CH 595106 A5 CH595106 A5 CH 595106A5 CH 279375 A CH279375 A CH 279375A CH 279375 A CH279375 A CH 279375A CH 595106 A5 CH595106 A5 CH 595106A5
Authority
CH
Switzerland
Application number
CH279375A
Inventor
Robert Fontanges
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH595106A5 publication Critical patent/CH595106A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH279375A 1974-03-05 1975-03-05 CH595106A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7407352A FR2262962B1 (de) 1974-03-05 1974-03-05

Publications (1)

Publication Number Publication Date
CH595106A5 true CH595106A5 (de) 1978-01-31

Family

ID=9135822

Family Applications (1)

Application Number Title Priority Date Filing Date
CH279375A CH595106A5 (de) 1974-03-05 1975-03-05

Country Status (12)

Country Link
US (1) US4136168A (de)
JP (1) JPS50160487A (de)
BE (1) BE826275A (de)
CA (1) CA1052306A (de)
CH (1) CH595106A5 (de)
DE (1) DE2508396A1 (de)
DK (1) DK141172B (de)
ES (1) ES435323A1 (de)
FR (1) FR2262962B1 (de)
GB (1) GB1469901A (de)
NL (1) NL7502623A (de)
ZA (1) ZA751357B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905678A1 (de) * 1978-02-16 1979-12-20 Science Union & Cie Pharmazeutische zubereitungen auf der grundlage von bakterienenzymen
CA1122527A (en) * 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
US4365187A (en) * 1980-05-15 1982-12-21 Rotron Incorporated Brushless D.C. motor
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029763A (en) * 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same

Also Published As

Publication number Publication date
FR2262962B1 (de) 1977-11-04
FR2262962A1 (de) 1975-10-03
BE826275A (fr) 1975-09-04
DK141172C (de) 1980-07-14
DE2508396A1 (de) 1975-10-23
ZA751357B (en) 1976-02-25
US4136168A (en) 1979-01-23
AU7878175A (en) 1976-09-09
CA1052306A (fr) 1979-04-10
GB1469901A (en) 1977-04-06
DK141172B (da) 1980-01-28
NL7502623A (nl) 1975-09-09
DK85775A (de) 1975-11-03
JPS50160487A (de) 1975-12-25
ES435323A1 (es) 1976-12-16

Similar Documents

Publication Publication Date Title
FR2285021B1 (de)
FR2294960B1 (de)
FR2259413A1 (de)
FR2262962B1 (de)
JPS50102079A (de)
FI752981A (de)
JPS50108884U (de)
JPS50131636A (de)
JPS50129682A (de)
JPS50132411A (de)
JPS50105503U (de)
JPS50101032U (de)
FI740356A0 (de)
JPS50135184A (de)
JPS50136171A (de)
AR198841Q (de)
CH576591A5 (de)
CH570190A5 (de)
CH577886A5 (de)
CH577817A5 (de)
BG26378A3 (de)
BG26532A3 (de)
CH576268A5 (de)
CH575605A5 (de)
CH575130A5 (de)

Legal Events

Date Code Title Description
PL Patent ceased